Navigation Links
Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
Date:5/22/2008

IRVINE, Calif., May 22 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, was awarded a three-year contract with HealthTrust Purchasing Group, LP (HealthTrust) to provide intravascular temperature management products to the group purchasing organization's (GPO) extensive network of over 1,400 not-for-profit and for-profit acute care hospitals.

"This is the fourth contract we have been awarded by a major hospital GPO in the U.S.," said Bill Worthen, president and chief executive officer of Alsius. "We are pleased that our intravascular temperature management solution was chosen by HealthTrust and we look forward to working together to introduce our product offerings to its members."

About Alsius IVTM(TM)

Alsius IVTM consists of the CoolGard 3000(R), Thermogard(TM) and Thermogard XP(TM) systems and a family of single-use catheters, including the Cool Line(R), Icy(R), Fortius(R) and Quattro(TM) catheters. The catheters are inserted into a major vein through a patient's neck or groin, and circulate cool or warm saline in a closed-loop through balloons that surround the catheters. This approach decreases or increases core temperature from the inside of the body out toward the exterior, allowing for significantly more rapid control of a patient's core body temperature, with greater efficiency and precision, compared to conventional external temperature management products such as cooling and warming blankets and ice packs.

About Alsius Corporation

Alsius, headquartered in Irvine, Calif., is a medical device company that develops, manufactures and sells proprietary products to precisely contr
'/>"/>

SOURCE Alsius Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
2. Alsius Corporation Receives Regulatory Approval in China and Mexico
3. Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financial Results
4. Alsius Corporation Announces Program for Early Exercise of Warrants
5. Alsius Corporation to Host Third Quarter 2007 Financial Results Conference Call/Webcast on November 13, 2007
6. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
7. Conseco Shareholders Re-Elect 10 Directors, Approve Two Amendments To Certificate Of Incorporation And Ratify Independent Registered Public Accounting Firm
8. Volcano Corporation Presentation at JMP Conference to be Webcast
9. Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers
10. Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... By Maureen Salamon ... (HealthDay News) -- For the millions of women who ... researchers are testing a treatment that uses stem cells ... pilot study, European researchers found that injecting stem cells ... stress incontinence in all participants within a year. ...
(Date:7/11/2014)... the era of personalized medicine may be just around ... Cell researcher Min Yu and scientists at Massachusetts General ... 11 study in Science , Yu and her ... through the blood streams of six patients. Some of ... which travel to and establish secondary tumors in vital ...
(Date:7/11/2014)... OR (PRWEB) July 11, 2014 Recent research ... life, health, the atmosphere, and how water affects human bodies. ... Water, Gerald Pollack, during an interview on the Sharon Kleyne ... , Gerald Pollack, PhD, is a Professor ... is The Fourth Phase of Water (Ebner & Sons, 2013). ...
(Date:7/11/2014)... 2014 Cancer researchers in Slovenia say ... impact on how patients respond to treatment with pemetrexed ... Mesothelioma has the full story. Click here to ... the University of Ljubljana and the Ljubljana Institute of ... different types of polymorphisms. They found that patients with ...
(Date:7/11/2014)... 11, 2014 Shoulder instability is a ... return to play has not been regularly determined following ... Society for Sports Medicine’s ( AOSSM ) Annual Meeting ... approximately 90 percent no matter what the stabilization procedure ... rate of return to play following shoulder stabilization surgery. ...
Breaking Medicine News(10 mins):Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2
... April 16 The California Dental Association ... is rapidly approaching to have your kindergartener receive a ... school year.The requirement has been in effect for two ... chronic childhood disease, it is essential that children develop ...
... April 16 The 6th annual North Carolina "Give Kids ... children being treated across the state, a 26% increase over ... increase of $710,000 (56%) compared to last year. The event ... assistants and other volunteers took part in the program, which ...
... could keep them younger, longer , , THURSDAY, April 16 ... insights into how cells and tissues may stay youthful ... by cells to stay alive when oxygen levels are ... defend against some age-related diseases, a new study finds. ...
... gallons of bottled water were consumed in 2000, an increase ... consumers drink more bottled water because it is an alternative ... is unclear, but one thing is certain: they are missing ... helps to protect teeth from cavities, according to a study ...
... & Conference Track will Offer Attendees the Latest Resources ... April 16 With consumers paying closer attention to ... private label and contract manufacturer resources, the new Private ... a hotbed of activity. Taking place September 15-17, ...
... Service hospitals, usage by stroke rehab patients dictates increase ... Saebo, Inc. announced in its first quarter that its ... 2008 and has added staff to accommodate its continued ... Saebo UK," said UK Managing Director, Glyn Blakey. "In ...
Cached Medicine News:Health News:California Dental Association Reminds Parents of Kindergarten Dental Check-Up Requirement 2Health News:Worms Reveal More of Longevity's Secrets 2Health News:Parents: Bottled Water Trend Poses Threat to Dental Health 2Health News:Parents: Bottled Water Trend Poses Threat to Dental Health 3Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 2Health News:HBA Global Expo Platforms Private Label/Contract Manufacturing 3Health News:Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009 2
(Date:7/11/2014)... 11, 2014 Research and Markets ( ... "Immunoprotein Diagnostic Testing Market - Forecasts to ... of 6% and is expected to be valued ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... has been segmented according to immunoprotein types which ...
(Date:7/11/2014)... SAN DIEGO , July 11, 2014 ... Therapies Corp. ("Biotie") to end the option held by ... to commence further development of NRL-1 (intranasal diazepam) for ... seizures. Over the past year, Biotie has ... Neurelis in preparation for the pivotal clinical work required ...
(Date:7/10/2014)... 2014  The U.S. Department of Health and Human ... Hospitals (UH) Case Medical Center Seidman Cancer Center totaling ... at improving care for patients with complex cancer. ... test a unique model developed at UH to enhance ... comorbidities, or demonstrated need for high health care utilization.  ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: